MedPath

Serum albumin-adjusted glycated albumin is a useful indicator of glycemic control in diabetic patients with end-stage renal disease not on hemodialysis

Not Applicable
Conditions
Patients with diabetic nephropathy CKD4-5
Registration Number
JPRN-UMIN000015174
Lead Sponsor
Kurume University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

cancer

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Association between SA-adjusted GA and glycemic control
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath